Clarion Pharmaceuticals (1672.HK) 2023 Interim Results Conference
Risk Disclaimer: The above content only represents the author's view. It does not represent any position or investment advice of Futu. Futu makes no representation or warranty.Read more
Comments (3)
to post a comment
7